Medtronic plc, (NYSE: MDT), a global leader in healthcare technology, today announced continued momentum for the Affera™ family of technologies for cardiac arrhythmia treatment, including promising ...
Findings from the AltaValve Early Feasibility Study suggest that patients with a leaky mitral valve have sustained clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results